UK markets close in 4 hours 38 minutes

Merck & Co., Inc. (0QAH.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
89.70+0.19 (+0.22%)
As of 06:10PM GMT. Market open.
Full screen
Previous close89.51
Bid0.00 x N/A
Ask0.00 x N/A
Day's range89.12 - 89.48
52-week range84.53 - 119.56
Avg. volume63,990
Market capN/A
Beta (5Y monthly)0.39
PE ratio (TTM)0.16
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Yahoo Finance

    Moderna CEO: 2024 is year of growth, with 2023 transition in rearview

    Moderna posted strong results despite investors assuming a loss for the year.

  • Yahoo Finance Video

    Apple, Amazon, Meta earnings on deck, Peloton sinks: Yahoo Finance Live

    All eyes are on three of the biggest names in tech, with investors watching earnings reports from Amazon (AMZN), Apple (AAPL), and Meta Platforms (META). Another name on the move is Peloton Interactive (PTON). Peloton shares have plummeted more than 20 percent on disappointing earnings and guidance. Other trending tickers on Yahoo Finance include Qualcomm (QCOM), Ferrari (RACE), and Merck (MRK). Top guests on Yahoo Finance Live today include: 3:05 p.m. ET - Luke Kawa, UBS Asset Management. Asset Allocation Strategist3:20 p.m. ET - Naftali Holtz, Royal Caribbean Group CFO4:15 p.m. ET - Aaron Kessler, Seaport Global Analyst4:30 p.m. ET - Santosh Rao, Manhattan Venture Partners Head of Research4:45 p.m. ET - Andy Challenger, Challenger, Gray & Christmas Senior Vice President

  • Yahoo Finance Video

    Merck cancer drug boosts Q4 revenue by 21% year-over-year

    Pharmaceutical company Merck (MRK) has reported fourth-quarter earnings, beating top and bottom line estimates with revenue significantly boosted year-over-year by demand for its cancer drug Keytruda. Yahoo Finance’s Brad Smith and Seana Smith take a closer look at the company’s numbers and the future of its product pipeline. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Eyek Ntekim